Strengthening local genomic capacity at WHX Labs Dubai 2026

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

Medicover Genetics concluded a successful participation at WHX Labs Dubai 2026, where discussions centred on expanding local genomic expertise and incorporating sustainable precision health initiatives across the region. Over four days of innovation, networking and knowledge exchange, we connected with professionals from around the world and shared our vision for advancing genetic diagnostics.

Advancing Local Genomic Testing

A central highlight of our participation was the presentation delivered by Dr Stefan Christoph Mehrle, Head of Business Unit Genetics, as part of the Precision Health World Forum 2026 – Technology and Innovation Spotlight sessions, which focus on shaping the future of genomic medicine in the Gulf. We extend our sincere thanks to everyone who attended the session, “Scalable Technology Transfer Platform to Accelerate Local Genomic Testing Capacity in Precision Health,” and to the many laboratory professionals and partners who connected with our team during the event. Dr. Mehrle outlined how a structured technology transfer platform enables laboratories to deploy high-fidelity genomic workflows locally by integrating wet lab protocols with validated bioinformatics pipelines. The discussion emphasized scalability across multiple clinical applications, including prenatal, oncology, reproductive, neonatal, and postnatal testing, while maintaining operational consistency.

Harmonized quality systems, supported by ISO-certified and CAP-accredited laboratory frameworks, were highlighted as essential to achieving long-term diagnostic autonomy.

From Standards to Sustainable Impact

WHX Labs Dubai 2026 reinforced a shared ambition: strengthening regional precision health ecosystems by bringing advanced genetic testing closer to patients.

Through CE-IVD and IVDR-compliant assay portfolios and structured deployment support, Medicover Genetics continues to in localizing genomic services and building sustainable testing capacity.

We appreciate the valuable discussions and look forward to continuing the conversation beyond WHX Labs Dubai 2026. For further information about Medicover Genetics’ scalable genomic solutions and Technology Transfer Platform, visit our website.

Last updated: 07.10.2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases

  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?